Shane Kovacs
2016 - PTC Therapeutics
In 2016, Shane Kovacs earned a total compensation of $2.1M as Executive Vice President, Chief Financial Officer and Head of Corporate Development at PTC Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $146,033 |
|---|---|
| Option Awards | $1,533,672 |
| Salary | $429,510 |
| Other | $15,552 |
| Total | $2,124,767 |
Kovacs received $1.5M in option awards, accounting for 72% of the total pay in 2016.
Kovacs also received $146K in non-equity incentive plan, $429.5K in salary and $15.6K in other compensation.
Rankings
In 2016, Shane Kovacs' compensation ranked 4,615th out of 14,075 executives tracked by ExecPay. In other words, Kovacs earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,615 out of 14,075 | 67th |
Division Manufacturing | 1,636 out of 5,489 | 70th |
Major group Chemicals And Allied Products | 507 out of 1,895 | 73rd |
Industry group Drugs | 375 out of 1,538 | 76th |
Industry Pharmaceutical Preparations | 296 out of 1,176 | 75th |
Source: SEC filing on April 27, 2017.
Kovacs' colleagues
We found four more compensation records of executives who worked with Shane Kovacs at PTC Therapeutics in 2016.